Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

KV Official Is Excluded From Government Programs, The First Under OIG's New Guidance

This article was originally published in The Pink Sheet Daily

Executive Summary

Former CEO Marc Hermelin resigns from KV's board to prevent the company's exclusion; KV dissolved Ethex under agreement with OIG.

You may also be interested in...



Ranbaxy Fraud Settlement Emphasizes Guilty Pleas, Downplays Exclusion

Although pharmaceutical company settlements in the millions of dollars now seem customary, a guilty plea to seven felonies could signal aggressive government pursuit of manufacturing and data integrity concerns.

OIG Exclusion Power Complicating Consent Decree Negotiations

Companies are having a tougher time negotiating corporate integrity agreements since HHS' Office of Inspector General has intensified its efforts to exclude individuals from federal health care programs.

OIG Exclusion Power Complicating Consent Decree Negotiations

Companies are having a tougher time negotiating corporate integrity agreements since HHS' Office of Inspector General has intensified its efforts to exclude individuals from federal health care programs.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS071459

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel